CONTRAINDICATIONS OF BIOLOGICAL-OXIDATION INHIBITORS IN THE TREATMENT OF PORPHYRIA.
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000927:Anticonvulsants; D000935:Antifungal Agents; D058633:Antipyretics; D001463:Barbiturates / Q000633:toxicity*; D002707:Chlordiazepoxide; D006993:Hypnotics and Sedatives; D008620:Meprobamate; D009249:NADP; D010084:Oxidation-Reduction; D010600:Pharmacology; D011164:Porphyrias; D014116:Toxicology
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000927:Anticonvulsants; D000935:Antifungal Agents; D058633:Antipyretics; D001463:Barbiturates; D006993:Hypnotics and Sedatives; D009249:NADP; D002707:Chlordiazepoxide; D008620:Meprobamate; C032232:barbituric acid
ANALGESICS AND ANTIPYRETICS; ANTICONVULSANTS; ANTIFUNGAL AGENTS; BARBITURATE TOXICOLOGY; CHLORDIAZEPOXIDE; HYPNOTICS AND SEDATIVES; MEPROBAMATE; NADP; OXIDATION-REDUCTION; PHARMACOLOGY; PORPHYRIA; TOXICOLOGIC REPORT